Table 5.
UGT2B7 polymorphisms affect efficacy of VPA.
| Genotype | Good efficacy, n (%) | Poor efficacy, n (%) | χ2 | P |
|---|---|---|---|---|
| A268G | 1.759 | 0.415 | ||
| AA | 4 | 2 | ||
| AG | 24 | 26 | ||
| GG | 18 | 27 | ||
| C802T | 9.265 | 0.010 | ||
| CC | 9 | 2 | ||
| CT | 23 | 27 | ||
| TT | 30 | 11 | ||
| G211T | 0.565 | 0.754 | ||
| GG | 48 | 26 | ||
| GT | 15 | 11 | ||
| TT | 1 | 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.